| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b82f96f476d23a7668947a83cdaefcc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4319fe3d827bd24add491d4ed90e7692 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate |
2013-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-04-04^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04827ef7d1f0a85cba95bc10d0bb3a95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4128ccae8cf165e9c8a16b053404e66b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc024cce09d55f5f66d2c5aadbe82e1e |
| publicationDate |
2017-04-04^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9609861-B2 |
| titleOfInvention |
Platelet additive solution having a β-galactosidase inhibitor |
| abstract |
The present invention relates to a platelet additive solution (PAS) having an amount of one or more β-galactosidase inhibitors with or without an amount of one or more sialidase inhibitors, and optionally one or more glycan-modifying agents; and one or more of PAS components that include a salt, a citrate source, a carbon source, or any combination thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541105-B2 |
| priorityDate |
2011-05-17^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |